Skip to main content
. 2020 Nov 16;19:240. doi: 10.1186/s12944-020-01418-0

Table 3.

Relationship between the incidence of the primary endpoint and the AIP expressed as a categorical variable

Variables Univariate analysis
HR (95% CI)
P-value Multivariate analysis
HR (95% CI)
P-value
AIP quartiles
 Q1 Reference Reference
 Q2 1.376 (0.878–2.156) 0.164 1.167 (0.733–1.857) 0.516
 Q3 1.710 (1.109–2.636) 0.015 1.570 (0.995–2.478) 0.053
 Q4 2.265 (1.491–3.440) < 0.001 2.249 (1.438–3.517) < 0.001
Age 1.005 (0.991–1.019) 0.472 0.996 (0.980–1.012) 0.642
BMI 0.959 (0.916–1.005) 0.078 0.922 (0.876–0.970) 0.002
Hypertension 1.068 (0.789–1.447) 0.669 1.241 (0.890–1.729) 0.203
Previous MI 1.492 (1.095–2.033) 0.011 0.781 (0.532–1.145) 0.205
Past PCI 1.723 (1.285–2.310) < 0.001 1.263 (0.734–2.080) 0.425
PAD 2.511 (1.836–3.435) < 0.001 1.717 (1.192–2.473) 0.004
Cardiac failure 1.951 (1.308–2.909) 0.001 1.165 (0.677–2.004) 0.581
LVEF 0.974 (0.959–0.990) 0.002 0.983 (0.962–1.004) 0.120
SCr 1.013 (1.006–1.021) 0.001 1.010 (1.002–1.019) 0.014
LDL-C 1.078 (0.916–1.269) 0.366 1.028 (0.852–1.239) 0.774
FPG 1.201 (1.132–1.274) < 0.001 1.156 (1.087–1.230) < 0.001
Clinical presentation
 UAP Reference Reference
 NSTEMI 0.677 (0.416–1.102) 0.117 0.467 (0.275–0.792) 0.005
 STEMI 1.098 (0.690–1.747) 0.695 0.850 (0.508–1.424) 0.538
CAD severity
 One-vessel disease Reference Reference
 Two-vessel disease 1.756 (0.809–3.810) 0.154 1.230 (0.549–2.755) 0.615
 LM/three-vessel disease 3.541 (1.740–7.205) < 0.001 1.823 (0.858–3.873) 0.118
Restenotic lesions 2.290 (1.658–3.163) < 0.001 1.667 (0.914–3.040) 0.095
Lesions > 20 mm long 1.984 (1.461–2.695) < 0.001 1.566 (1.129–2.174) 0.007
DCB use 1.913 (1.228–2.980) 0.004 0.990 (0.571–1.715) 0.970
Complete revascularization 0.467 (0.352–0.619) < 0.001 0.687 (0.504–0.936) 0.017
Insulin at discharge 1.396 (1.051–1.854) 0.021 1.056 (0.775–1.438) 0.730

Abbreviations as in Tables 1 and 2